Company Filing History:
Years Active: 2016-2021
Title: Ioana Combaluzier: Innovator in Immunotherapy
Introduction
Ioana Combaluzier is a prominent inventor based in Urdorf, Switzerland. She has made significant contributions to the field of immunotherapy, particularly through her work on human islet amyloid polypeptide (hIAPP) specific antibodies. With a total of three patents to her name, Combaluzier is recognized for her innovative approaches to medical diagnostics and treatment.
Latest Patents
Combaluzier's latest patents focus on novel human islet amyloid polypeptide specific antibodies and their various applications. These patents include methods related to the development of antibodies, fragments, derivatives, and variants that target IAPP and proIAPP. The disclosed assays, kits, and solid supports are designed for use in pharmaceutical and diagnostic compositions aimed at IAPP and proIAPP targeted immunotherapy and diagnostics.
Career Highlights
Ioana Combaluzier is currently associated with Neurimmune Holding AG, where she continues to advance her research in immunotherapy. Her work has garnered attention for its potential impact on treating conditions related to amyloid polypeptides.
Collaborations
Combaluzier collaborates with notable colleagues such as Jan Grimm and Fabrice Heitz, contributing to a dynamic research environment that fosters innovation in the field of immunotherapy.
Conclusion
Ioana Combaluzier stands out as a leading inventor in the realm of immunotherapy, with her patents paving the way for advancements in medical diagnostics and treatment. Her contributions are vital to the ongoing research and development in this important area of healthcare.